CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
Part of paid clinical trials in Thousand Oaks, California.
- Sponsor
- EmStop Inc
- Study ID
- NCT07276711
- Status
- Recruiting
Conditions
- Aortic Stenosis
- Aortic Valve Disease
- Aortic Valve Stenosis
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- EmStop Embolic Protection System — DEVICEEmStop Embolic Protection System used during TAVR procedure
- Boston Scientific Sentinel — DEVICESentinel device used during TAVR procedure
Study Details
The objective of this study is to demonstrate safety and efficacy of the EmStop Embolic Protection System when used as indicated to capture and remove thrombus/debris during self-expanding transcatheter aortic valve replacement (TAVR) procedures.
Key Dates
- First listed
- Dec 11, 2025
- Start date
- May 12, 2026
- Status verified
- Aug 2026
- Primary completion
- May 31, 2028
- Completion
- May 31, 2028
Study Design
- Enrollment
- 663 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: EmStop System
- Active Comparator: Boston Scientific Sentinel device
Primary Outcome Measure
Non-Inferiority [ Time Frame: Non-inferiority of 30-day EmStop device MACCE patient incidence rate compared to the Sentinel device patient incidence rate ]
Central Contacts
- Katherine Vo763-227-9954
- Danielle Gustafson612-345-4544
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Los Robles Regional Medical Center | Thousand Oaks | California | 91360 | Saibal Kar, MD (PRINCIPAL_INVESTIGATOR) |
| Morton Plant Hospital | BayCare Health | Clearwater | Florida | 33756 | Joshua Rovin, MD (PRINCIPAL_INVESTIGATOR) |
| Ochsner Medical Center | New Orleans | Louisiana | 70121 | James S Jenkins, MD (PRINCIPAL_INVESTIGATOR) |
| University of Michigan Health | Michigan Medicine | Ann Arbor | Michigan | 48109 | Paul M Grossman, MD (PRINCIPAL_INVESTIGATOR) |
| Mission Health | Asheville | North Carolina | 28801 | Michaeal Chenier, MD (PRINCIPAL_INVESTIGATOR) |
| Monument Health Heart and Vascular Institute | Rapid City | South Dakota | 57701 | Joseph Tuma, MD (PRINCIPAL_INVESTIGATOR) |
| Methodist Research Institute | San Antonio | Texas | 78229 | Jorge Alvarez, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Thousand Oaks, CA
By research site
Related Studies
- PARTNER 3 Trial - Aortic Valve-in-ValveRecruiting · Edwards Lifesciences · Phoenix, Arizona
- Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve ReplacementRecruiting · University of British Columbia · Huntsville, Alabama
- Valved Graft PMCF StudyRecruiting · Abbott Medical Devices · Ann Arbor, Michigan
- PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVRRecruiting · Edwards Lifesciences · Huntsville, Alabama